The FDA has cleared Nexera Medical‘s (Richmond, British Columbia) SpectraShield 9500 surgical respirator, a face mask the outside of which has been shown to kill three types of bacteria (Streptococcus pyogenes, Methicillin-resistant Staphylococcus aureus (MRSA), and Haemophilus influenzae). The device is also a certified N95 respirator, blocking at least 95% of dust particles.
From the product page:
• Superior filtration of N95 performance
• Continuous protection against bacteria.
• Exceeds the U.S. Center for Disease Control (“CDC”) and World Health Organization (“WHO”) guidelines for protection against infectious microbial threats such as Avian Influenza, SARS and Tuberculosis.
• Patented proven technology incorporating a U.S. Environmental Protection Agency (“EPA”) approved antimicrobial agent which is embedded into the fiber for enhanced protection.
• Fluid Resistance which reduces the risk and meets the requirements for ASTM Fluid Resistance. (“Resistance of Medical Face Masks to Penetration by Synthetic Blood” – at a minimum pressure of 120 mm Hg.)
• Reduces mask odor caused by bacterial growth.
• Continuously self-sanitizes itself for extended use.
• Natural nontoxic antimicrobial agent is safe for wear.
Press release: FDA clears single-use antibacterial surgical respirator…
Product page: SpectraShield 9500…
